FibroGen's total assets for Q3 2024 were $264.42M, a decrease of -9.82% from the previous quarter. FGEN total liabilities were $466.12M for the fiscal quarter, a -3.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.